Spandow Oliver J. 4
4 · NEPHROS INC · Filed Jan 3, 2025
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Spandow Oliver J.
Director
Transactions
- Award
Common Stock
2025-01-01+33,241→ 114,845 total - Award
Stock Option (Right to Buy)
2025-01-01+7,050→ 7,050 totalExercise: $1.47Exp: 2035-01-01→ Common Stock (7,050 underlying)
Holdings
- 9,466
Stock Option (Right to Buy)
Exercise: $5.58Exp: 2028-08-10→ Common Stock (9,466 underlying) - 7,062
Stock Option (Right to Buy)
Exercise: $6.82Exp: 2031-12-14→ Common Stock (7,062 underlying) - 7,080
Stock Option (Right to Buy)
Exercise: $1.07Exp: 2033-01-05→ Common Stock (7,080 underlying) - 5,161
Stock Option (Right to Buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (5,161 underlying) - 6,850
Stock Option (Right to Buy)
Exercise: $8.06Exp: 2031-01-06→ Common Stock (6,850 underlying) - 5,568
Stock Option (Right to Buy)
Exercise: $8.57Exp: 2029-12-16→ Common Stock (5,568 underlying) - 7,323
Stock Option (Right to Buy)
Exercise: $2.14Exp: 2034-05-14→ Common Stock (7,323 underlying)
Footnotes (4)
- [F1]Fully exercisable.
- [F2]This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
- [F3]This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
- [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.